Ignite Creation Date:
2024-05-05 @ 4:35 PM
Last Modification Date:
2024-10-26 @ 9:22 AM
Study NCT ID:
NCT00275197
Status:
COMPLETED
Last Update Posted:
2008-11-02
First Post:
2006-01-09
Brief Title:
A Research Study to Compare the Treatments of a Combination of Elzasonan With Zoloft to Zoloft Alone or Placebo in People With Major Depressive Disorder MDD
Sponsor:
Pfizer
Organization:
Pfizer
Study Overview
Official Title:
An Eight-Week Double-Blind Group-Sequential Design Placebo Controlled Trial To Evaluate The Safety And Efficacy Of The Co- Administration Of Sertraline And Elzasonan CP-448187 In Outpatients With Major Depressive Disorder
Status:
COMPLETED
Status Verified Date:
2008-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The major purpose of the study is to help determine whether giving the combination of Elzasonan with Zoloft to people with depression is a better treatment than taking Zoloft alone This study will also compare the safety and tolerability of Elzasonan and Zoloft combination to Zoloft alone or placebo
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None